ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 42 filers reported holding ITERUM THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $207,000 | – | 89,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,538,316 | $10,307,000 | 1.89% |
| New Leaf Venture Partners, L.L.C. | 1,456,303 | $9,648,000 | 1.76% |
| Sofinnova Investments, Inc. | 1,726,514 | $11,438,000 | 1.02% |
| Cormorant Asset Management, LP | 476,968 | $3,196,000 | 0.21% |
| Granahan Investment Management | 250,717 | $1,661,000 | 0.09% |
| TIVERTON ASSET MANAGEMENT LLC | 140,448 | $941,000 | 0.05% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,000 | $670,000,000 | 0.02% |
| Neuburgh Advisers LLC | 61,676 | $413,000 | 0.01% |
| Flinton Capital Management LLC | 50,792 | $340,000 | 0.01% |
| Tyers Asset Management LLC | 39,908 | $268,000 | 0.01% |